Synta Pharmaceuticals in Potential $1 Billion Pact with Roche (JOBS), Synta to Receive $25 Million Upfront

Dec 30 (Reuters) - Synta Pharmaceuticals Corp said it entered into a collaboration and licensing agreement with Roche for the development and marketing of certain compounds to treat inflammatory diseases, sending its shares up 10 percent.